Sarepta Therapeutics (SRPT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to -$851.0 million.
- Sarepta Therapeutics' Enterprise Value rose 2898.67% to -$851.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$851.0 million, marking a year-over-year increase of 2898.67%. This contributed to the annual value of -$1.4 billion for FY2024, which is 4828.58% up from last year.
- Per Sarepta Therapeutics' latest filing, its Enterprise Value stood at -$851.0 million for Q3 2025, which was up 2898.67% from -$963.0 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Enterprise Value ranged from a high of -$851.0 million in Q3 2025 and a low of -$2.6 billion during Q4 2023
- Moreover, its 5-year median value for Enterprise Value was -$1.7 billion (2023), whereas its average is -$1.7 billion.
- Per our database at Business Quant, Sarepta Therapeutics' Enterprise Value crashed by 3168.8% in 2023 and then soared by 4828.58% in 2024.
- Sarepta Therapeutics' Enterprise Value (Quarter) stood at -$2.1 billion in 2021, then rose by 5.98% to -$2.0 billion in 2022, then plummeted by 31.69% to -$2.6 billion in 2023, then surged by 48.29% to -$1.4 billion in 2024, then skyrocketed by 37.18% to -$851.0 million in 2025.
- Its last three reported values are -$851.0 million in Q3 2025, -$963.0 million for Q2 2025, and -$894.2 million during Q1 2025.